Cargando…
CD11c-CD8 Spatial Cross Presentation: A Novel Approach to Link Immune Surveillance and Patient Survival in Soft Tissue Sarcoma
SIMPLE SUMMARY: Immune cells can be powerful regulators of tumor growth and disease progression. Yet, the potential role of professional antigen-presenting cells in soft tissue sarcoma is poorly explored. Both dendritic cells and macrophages may present exogenous antigens through major histocompatib...
Autores principales: | Su, Yanhong, Tsagkozis, Panagiotis, Papakonstantinou, Andri, Tobin, Nicholas P., Gultekin, Okan, Malmerfelt, Anna, Ingelshed, Katrine, Neo, Shi Yong, Lundquist, Johanna, Chaabane, Wiem, Nisancioglu, Maya H., Leiss, Lina W., Östman, Arne, Bergh, Jonas, Sedimbi, Saikiran, Lehti, Kaisa, Lundqvist, Andreas, Stragliotto, Christina L., Haglund, Felix, Ehnman, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967210/ https://www.ncbi.nlm.nih.gov/pubmed/33803245 http://dx.doi.org/10.3390/cancers13051175 |
Ejemplares similares
-
The Tumor Microenvironment of Pediatric Sarcoma: Mesenchymal Mechanisms Regulating Cell Migration and Metastasis
por: Ehnman, Monika, et al.
Publicado: (2019) -
Evaluation of PD-L1 Expression in Undifferentiated Pleomorphic Sarcomas, Liposarcomas and Chondrosarcomas
por: Zhang, Yifan, et al.
Publicado: (2022) -
CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
por: Jiang, Long, et al.
Publicado: (2022) -
MDM2 inhibitors, nutlin-3a and navtemadelin, retain efficacy in human and mouse cancer cells cultured in hypoxia
por: Lerma Clavero, Ada, et al.
Publicado: (2023) -
Current Status of Management and Outcome for Patients with Ewing Sarcoma
por: Hesla, Asle Charles, et al.
Publicado: (2021)